Treating erectile dysfunction when PDE5 inhibitors fail

British Medical Journal

Volumn 332, Issue 7541, 2006, Pages 589-592

  McMahon, Chelsea N ^a   Smith, Christopher J ^b   Shabsigh, Ridwan ^c  

^a ST VINCENT S HOSPITAL   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL; PHOSPHODIESTERASE INHIBITOR;

ANDROGEN THERAPY; COMORBIDITY; DRUG ACTIVITY; DRUG CLEARANCE; DRUG MECHANISM; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; MEDICAL INSTRUMENTATION; OPTIMAL DRUG DOSE; PATIENT EDUCATION; PATIENT REFERRAL; PENIS PROSTHESIS; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEXUAL COUNSELING; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE; VACUUM CONSTRICTION DEVICE; DRUG COMBINATION; IMPOTENCE; LIFESTYLE; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; RISK FACTOR; VACUUM;

ADMINISTRATION, ORAL; DRUG THERAPY, COMBINATION; HUMANS; IMPOTENCE; LIFE STYLE; MALE; PATIENT EDUCATION; PENILE PROSTHESIS; PHOSPHODIESTERASE INHIBITORS; PSYCHOTHERAPY; REFERRAL AND CONSULTATION; RISK FACTORS; TESTOSTERONE; TREATMENT FAILURE; VACUUM;

EID: 33644937450     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7541.589     Document Type: Review

References (30)

1. Fagelman E, Fagelman A, Shabsigh R. Efficacy, safety, and use of sildenafil in urologic practice. Urology 2001;57:1141-4.
2. Atiemo HO, Szostak MJ, Sklar GN. Salvage of sildenafil failures referred from primary care physicians. J Urol 2003;170:2356-8.
3. McCullough AR, Barada JH, Fawzy A, Guay AT, Hatzichristou D. Achieving treatment optimisation with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology 2002;60(suppl):28.
4. Pfizer Corporation. Viagra® (sildenafil HCl) tablets: prescribing information (online). http://pfizer.com/download/uspi_viagra.pdf (accessed 6 Mar 2005).
5. Bayer AG. Levitra® (vardenafil HCl) tablets: prescribing information (online). www.univgraph.com/bayer/inserts/levitra.pdf. (accessed 6 Mar 2005).
6. Eli Lilly Corporation. Cialis (tadalafil HCl) tablets: prescribing information (online). www.cialis.com/prescribe/index.jsp?location= prescribing (accessed 6 Mar 2005).
7. McMahon CG. High dose sildenafil citrate as salvage therapy for severe erectile dysfunction. Int J Impot Res 2002;14(6):533-8.
8. El-Galley R, Rutland H, Talic R, Keane T, Clark H. Long-term efficacy of sildenafil and tachyphylaxis effect. J Urol 2001;166:927-31.
9. Lin G, Xin Z, Lue TF, Lin C. Up and down regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 2003;170:S15-9.
10. McMahon CG. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J Sex Med 2004;1:292-300.
11. Guay AT, Perez JB, Jacobson J, Newton RA. Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001;22:793-7.
12. Althof SE. When an erection alone is not enough: biopsychosocial obstacles to lovemaking. Int J Impot Res 2002;14(suppl 1):S99-104.
13. Perelman MA. Integrating sildenafil: its impact on sex therapy. Sex Dyafunc Med 2000;1:98-104.
14. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilatation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol 2003;58:636-8.
15. Shabsigh R, Raymond JF, Olsson CA, O'Toole K, Buttyan R. Androgen induction of DNA synthesis in the rat penis. Urology 1998;52:723-8.
16. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 1999;140:1861-8.
17. Arver S, Dobs AS, Meikle AW, Allen RP, Sanders SW, Mazer NA. Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J Urol 1996;155:1604-8.
18. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Testosterone replacement therapy with testosterone gel 1% converts sildenafil non-responders to responders in men with erectile dysfunction and hypogonadism who failed prior sildenafil therapy [abstract]. J Urol 2003;169:247.
19. Kalinchenko SY, Kozlov GI, Gontcharov NP, Katsiya GV. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male 2003;6:94-9.
20. McMahon CG, Samali R, Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol 1999;162:1992-8.
21. Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring non-invasive therapy. Int J Impot Res 2002;14(suppl 1):S38-42.
22. Mydlo JH, Volpe MA, Macchia RJ. Initial results utilizing combination therapy for patients with suboptimal response to either alprostadil or sildenafil monotherapy. Eur Urol 2000;38:30-4.
23. De Rose AF, Giglio M, Traverso P, Lantieri P, Carmignani G. Combined oral therapy with sildenafil and doxazosin for die treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy. Int J Impot Res 2002;14:50-3.
24. Dula E, Keating W, Siami PF, Edmonds A, O'Neil J, Buttler S. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group. Urology 2000;56:130-5.
25. Vrijhof HJ, Delaere KP. Vacuum constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed aetiology. Br J Urol 1994;74:102-5.
26. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996;55:802-15.
27. Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000;55:477-80.
28. McMahon CG. Comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin E1 alone and a combination of all three in the management of impotence. Int J Impot Res 1991;3:133-42.
29. Carson CC. Penile prostheses: are they still relevant? BJU Int 2003;91:176-7.
30. Droggin D, Shabsigh R, Anastasiadis A. Antibiotic coating reduces penile prosthesis infection. J Sex Med 2005;2:565-8.